Rare diseases, trends and challenges for scientific advances: a snapshot of a decade of research in Brazil.

Concilium (Glen Rock, N.J.) Pub Date : 2024-10-01 Epub Date: 2024-09-14
Fábio de Oliveira Aquino, Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes
{"title":"Rare diseases, trends and challenges for scientific advances: a snapshot of a decade of research in Brazil.","authors":"Fábio de Oliveira Aquino, Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Brazil is home to around 13 million rare disease patients, which represents a significant challenge for biomedical research and public health. This descriptive and exploratory study analyzed research protocols on rare diseases submitted to Plataforma Brasil between 2013 and 2023, with the aim of identifying trends, challenges and opportunities for scientific progress in this area. The research evaluated variables such as the number of studies submitted and approved, sample characteristics, type of study, experimental design, research phase, participation in international networks, and epidemiological data (ICD). The results indicate a substantial increase in the number of protocols submitted over the period analyzed, with an average approval rate of 87.26%. Most of the studies were conducted in public institutions, highlighting the fundamental role of the public sector in rare disease research in Brazil. These findings suggest a growing investment and interest in research in this area, which could boost the development of new therapies and interventions, as well as supporting the formulation of more effective public policies to meet the needs of patients with rare diseases.</p>","PeriodicalId":520535,"journal":{"name":"Concilium (Glen Rock, N.J.)","volume":"24 19","pages":"126-144"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12019882/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Concilium (Glen Rock, N.J.)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Brazil is home to around 13 million rare disease patients, which represents a significant challenge for biomedical research and public health. This descriptive and exploratory study analyzed research protocols on rare diseases submitted to Plataforma Brasil between 2013 and 2023, with the aim of identifying trends, challenges and opportunities for scientific progress in this area. The research evaluated variables such as the number of studies submitted and approved, sample characteristics, type of study, experimental design, research phase, participation in international networks, and epidemiological data (ICD). The results indicate a substantial increase in the number of protocols submitted over the period analyzed, with an average approval rate of 87.26%. Most of the studies were conducted in public institutions, highlighting the fundamental role of the public sector in rare disease research in Brazil. These findings suggest a growing investment and interest in research in this area, which could boost the development of new therapies and interventions, as well as supporting the formulation of more effective public policies to meet the needs of patients with rare diseases.

罕见病、科学进步的趋势和挑战:巴西十年研究概况。
巴西有大约1300万罕见病患者,这对生物医学研究和公共卫生构成了重大挑战。这项描述性和探索性研究分析了2013年至2023年期间提交给platforma Brasil的罕见病研究方案,旨在确定该领域科学进步的趋势、挑战和机遇。该研究评估了诸如提交和批准的研究数量、样本特征、研究类型、实验设计、研究阶段、参与国际网络和流行病学数据(ICD)等变量。结果表明,在所分析的时间段内,提交的方案数量大幅增加,平均批准率为87.26%。大多数研究是在公共机构进行的,突出了公共部门在巴西罕见病研究中的基本作用。这些发现表明,对这一领域研究的投资和兴趣日益增加,这可能促进新疗法和干预措施的开发,并支持制定更有效的公共政策,以满足罕见病患者的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信